Skip to main content
Erschienen in: Journal of General Internal Medicine 12/2019

15.05.2019 | Viewpoint

Accountable Care Organizations’ Performance in Depression: Lessons for Value-Based Payment and Behavioral Health

verfasst von: Nathaniel Z Counts, JD, Glenda Wrenn, MD, MSHP, David Muhlestein, PhD, JD

Erschienen in: Journal of General Internal Medicine | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Abstract

Value-based payment initiatives, such as the Medicare Shared Savings Program (MSSP), offer the possibility of using financial incentives to drive improvements in mental health and substance use outcomes. In the past 2 years, Accountable Care Organizations (ACOs) participating in the MSSP began to publicly report on one behavioral health outcome—Depression Remission at Twelve Months, which may indicate how value-based payment incentives have impacted mental health and substance use, and if reforms are needed. For ACOs that meaningfully reported performance on the depression remission measure in 2017, the median rate of depression remission at 12 months was 8.33%. A recent meta-analysis found that the average rate of spontaneous depression remission at 12 months absent treatment was approximately 53%. Although a number of factors likely explain these results, the current ACO design does not appear to incentivize improved behavioral health outcomes. Four changes in value-based payment incentive design may help to drive better outcomes: (1) making data collection easier, (2) increasing the salience of incentives, (3) building capacity to implement new interventions, and (4) creating safeguards for inappropriate treatment or reporting.
Literatur
1.
Zurück zum Zitat Busch AB, Huskamp HA, McWilliams JM. Early efforts by Medicare accountable care organizations have limited effect on mental illness care and management. Health Affairs. 2016 Jul 1;35(7):1247–56.CrossRef Busch AB, Huskamp HA, McWilliams JM. Early efforts by Medicare accountable care organizations have limited effect on mental illness care and management. Health Affairs. 2016 Jul 1;35(7):1247–56.CrossRef
2.
Zurück zum Zitat Pincus HA, Scholle SH, Spaeth-Rublee B, Hepner KA, Brown J. Quality measures for mental health and substance use: gaps, opportunities, and challenges. Health Affairs. 2016 Jun 1;35(6):1000–8.CrossRef Pincus HA, Scholle SH, Spaeth-Rublee B, Hepner KA, Brown J. Quality measures for mental health and substance use: gaps, opportunities, and challenges. Health Affairs. 2016 Jun 1;35(6):1000–8.CrossRef
3.
Zurück zum Zitat Whiteford HA, Harris MG, McKeon G, Baxter A, Pennell C, Barendregt JJ, Wang J. Estimating remission from untreated major depression: a systematic review and meta-analysis. Psychological medicine. 2013 Aug;43(8):1569–85.CrossRef Whiteford HA, Harris MG, McKeon G, Baxter A, Pennell C, Barendregt JJ, Wang J. Estimating remission from untreated major depression: a systematic review and meta-analysis. Psychological medicine. 2013 Aug;43(8):1569–85.CrossRef
4.
Zurück zum Zitat Fortney JC, Unützer J, Wrenn G, Pyne JM, Smith GR, Schoenbaum M, Harbin HT. A tipping point for measurement-based care. Psychiatric Services. 2016 Sep 1;68(2):179–88.CrossRef Fortney JC, Unützer J, Wrenn G, Pyne JM, Smith GR, Schoenbaum M, Harbin HT. A tipping point for measurement-based care. Psychiatric Services. 2016 Sep 1;68(2):179–88.CrossRef
5.
Zurück zum Zitat Marcotte L, Hodlofski A, Bond A, Patel P, Sacks L, Navathe AS. Into practice: How Advocate Health System uses behavioral economics to motivate physicians in its incentive program. Healthcare 2017 Sep 1;5(3): 129–135.CrossRef Marcotte L, Hodlofski A, Bond A, Patel P, Sacks L, Navathe AS. Into practice: How Advocate Health System uses behavioral economics to motivate physicians in its incentive program. Healthcare 2017 Sep 1;5(3): 129–135.CrossRef
6.
Zurück zum Zitat Dennehy EB, Robinson RL, Stephenson JJ, Faries D, Grabner M, Palli SR, Stauffer VL, Marangell LB. Impact of non-remission of depression on costs and resource utilization: from the COmorbidities and symptoms of DEpression (CODE) study. Current medical research and opinion. 2015 Jun 3;31(6):1165–77.CrossRef Dennehy EB, Robinson RL, Stephenson JJ, Faries D, Grabner M, Palli SR, Stauffer VL, Marangell LB. Impact of non-remission of depression on costs and resource utilization: from the COmorbidities and symptoms of DEpression (CODE) study. Current medical research and opinion. 2015 Jun 3;31(6):1165–77.CrossRef
Metadaten
Titel
Accountable Care Organizations’ Performance in Depression: Lessons for Value-Based Payment and Behavioral Health
verfasst von
Nathaniel Z Counts, JD
Glenda Wrenn, MD, MSHP
David Muhlestein, PhD, JD
Publikationsdatum
15.05.2019
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 12/2019
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05047-x

Weitere Artikel der Ausgabe 12/2019

Journal of General Internal Medicine 12/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.